Med-Adept : a lightweight assessment method for the Irish medical device software industry by Mc Caffery, Fergal & Casey, Valentine
1 
 
Med-Adept: A Lightweight Assessment Method for 
the Irish Medical Device Software Industry 
 
Fergal Mc Caffery, Valentine Casey 
Regulated Software Research Group 
Dundalk Institute of Technology 
And member of  
Lero- the Irish Software Engineering Research Centre, 
fergal.mccaffery@dkit.ie, val.casey@dkit.ie  
Keywords:  
Medical Device Assessment method, Software Process Improvement (SPI) 
Abstract  
In this paper we describe how a lightweight assessment method was developed to 
educate Irish software development organisations in relation to becoming medical 
device software suppliers.  
1 Introduction 
Two important sectors for the growth of the Irish economy are Medical Devices and 
Information and Communications Technology (ICT). The Medical Device (MD) and diagnostic 
industry is a  cornerstone of the Irish economy. The sector has been identified, by both the 
Irish Industrial Development Authority and Enterprise Ireland, as a key growth area. Of the 
world’s top 14 MD companies 11 have a base in Ireland; the indigenous base is also evolving 
rapidly; over 80% of the companies in this sector are involved in significant innovation.   
 
At present the Irish MD industry is focused on manufacturing. The sector is particularly 
dependent on the continued use of stents in the treatment of cardiovascular disease. 
Therefore, either the discovery of an effective drug treatment for vascular plague or the 
general migration of the manufacture of medical devices to low labour cost locations could 
negatively affect the future growth of the Irish MD sector. The Expert Group of Future Skills 
Needs (an Irish Government advisory body) [1], has highlighted ICT forms a major part of the 
MD sector globally, however in Ireland, where a significant ICT sector exists, only a small part 
of the MD sector involves ICT. The report also highlighted that Ireland does not have a strong 
presence in the production of electronic based medical devices (which would include 
substantial software development).  
 
There is therefore an opportunity to reduce the sectors dependence on stent manufacture by 
supporting the development of a software based MD industry in Ireland. This can be achieved 
through providing a range of services that will encourage existing indigenous MD companies 
to consider developing software and encourage multi-national MD companies to consider 
Ireland as a location for developing software. It will also provide opportunities for Irish 
software companies to develop software for the MD industry. However, to take up this 
opportunity they will need to demonstrate that their software development processes are both 
capable of producing high-quality software and achieving regulatory compliance.  Thus, there 
is a need for a low resource software process assessment to determine the current state of 
their software development practices.   
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2 Software for the Medical Device Industry 
Due to the safety-critical nature of medical devices, organisations developing MD software 
are expected to produce high-quality software through the use of defined processes. To 
tackle these issues, governments have put in place regulatory bodies to define regulatory 
systems for medical devices and to ensure that only safe medical devices are placed on the 
market.  To aid the control of medical devices, regulatory bodies have adopted a classification 
scheme.  The device manufacturer is obliged to establish and perform both pre-market and 
post-market duties as defined in the quality system regulations.  The quality system 
requirements for Europe are defined in the ANSI/AAMI/ISO 13485 standard [2] and the 
requirements for the U.S.A. are defined in the 21 CFR Part 820 Quality System Regulations 
[3]. Applicable requirements are typically directly related to the class of the device.   The 
regulatory or approved body, through its audits, checks conformance to the quality system 
requirements periodically.  
 
In an attempt to address the vagueness of the regulatory requirements, the FDA published 
separate regulatory guidance documents for required software activities [4,5,6].  In Europe, 
many organisations rely on the regulatory guidance documents from the FDA due to 
insufficient guidance provided for the equivalent CE marking process. Additionally, there has 
been a steady progression in the MD software sector with the release of new and updated 
standards in an attempt to address the knowledge gap that exists between the high-level 
regulatory requirements and the low level detail and knowledge required to adequately satisfy 
those requirements. 
   
Whenever we mention MD guidelines within this paper we refer to the following medical 
device standards and guidelines: ANSI/AAMI/IEC 62304 [7], FDA [4,5,6,8], European Council 
Guidelines [9], ISO 14971 [10], EN 60601-1-4 [11], GAMP 5 [12], TIR 32 [13], AAMI/IEC 
61508 [14], and IEC 60812 [15].  
3 Software Process for Medical Device Software Development 
With the development of formal SPI models such as CMMI
®
 [16] and ISO/IEC 15504-5 [17] 
researchers within regulated environments such as the Space and Automotive industries 
started to investigate how they could utilise these models to improve the practices within their  
industry domains. However, they discovered that although the existing models are 
comprehensive, neither CMMI
®
 nor ISO/IEC 15504-5 addressed all of the regulatory needs 
and constraints of their specific industries.  Researchers therefore sought to adopt the 
practices within these models while also expanding on them to account for regulatory 
requirements within their own domains.  This resulted in the production of full SPI models 
tailored specifically for the Space domain [18] and Automobile domain - Automotive SPICE 
[19].   
 
The authors are in the process of developing Medi SPICE which will be a comprehensive 
software process assessment model for the medical device industry [20] which is based on 
the AMMI/IEC 62304 standard, associated MD standards and guidelines (listed at the end of 
section 2) and ISO/IEC 15504-5. Medi SPICE like ISO/IEC 15504-5 and Automotive SPICE 
will contain both a Process Reference Model (PRM) and Process Assessment Model (PAM) 
that provide comprehensive coverage of the FDA and European Council guidelines, and 
associated standards (e.g. ISO 14971, IEC 60601-1-4,TIR 32 and GAMP) for the complete 
software development lifecycle. The overall objective of Medi SPICE is to provide a 
conformity assessment scheme to support first, second or third party assessment results that 
may be recognised by the regulatory bodies. The Medi SPICE PRM and PAM is being 
released in phases and once complete, will consist of a defined set of software processes that 
will contain base practices which when utilised will assist medical device software 
development organisations to fulfil the regulatory guidelines and standards of the medical 
device industry.  
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4 The Med-Adept Method  
One of the main goals of the Regulated Software Research Group in Dundalk Institute of 
Technology is to support the growth of a MD software development industry within Ireland. 
The authors previously developed the Adept method [21] which was based upon the ISO/IEC 
15504-5 and CMMI
®
 models. Consequently, we based the Med-Adept method upon relevant 
process areas from the CMMI
®
 and ISO/IEC 15504-5 models and included input from 
AAMI/IEC 62304. This therefore enabled the existing Adept questions to be established as 
the foundation for the new method and for additional questions to be added to enable 
coverage of relevant AAMI/IEC 62304 process areas. The Med-Adept method consists of an 
assessment component for each process that is deemed applicable for software development 
organisations wishing to become medical device software developers. However, even though 
each assessment component adopts a CMMI process area name, it provides coverage of 
CMMI
®
, ISO/IEC 15504-5 and AAMI/IEC 62304 practices through containing questions that 
relate to CMMI
®
, ISO/IEC 15504-5 and AAMI/IEC 62304 
A key decision in the development of the Med-Adept method was to decide what process 
areas should be included. The process areas included in Med-Adept were chosen because:- 
A. They have process area counterparts included within the  AAMI/IEC 62304 standard; 
B. They were previously included in the Adept method; 
We then analysed each of the CMMI
®
 process areas using the factors in Table 1 (see below). 
 
Table 1. Suitability of CMMI
®
 process areas for inclusion in Med-Adept method 
 
CMMI
®
 Process Area Satisfies 
A 
Satisfies  
B 
Requirements Management Yes Yes 
Project Planning Yes Yes 
Project Monitoring & Control Yes Yes 
Configuration Management Yes Yes 
Measurement & Analysis  Yes 
Process & Product QA Yes Yes 
Supplier Agreement Management   
Requirements Development Yes Yes 
Technical Solution Yes Yes 
Verification Yes Yes 
Product Integration Yes Yes 
Validation Yes Yes 
Organisational Process Focus   
Organisational Training   
Organisational Process Definition & 
IPPD 
  
Integrated Project Management & 
IPPD 
Yes  
Risk Management Yes Yes 
Decision Analysis & Resolution Yes  
Organisational Process Performance    
Quantitative Project Management   
Organisational Innovation & 
Deployment 
  
Causal Analysis & Resolution Yes  
 
Table 1, illustrates, that eleven of the twenty-two process areas from the CMMI
®
 model 
satisfied both factors and should be included in Med-Adept.  
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4.1 What processes are included in Med-Adept?  
In addition to the Med-Adept method enabling assessment against eleven CMMI
®
 process 
areas it should also assess ISO/IEC 15504-5 and AAMI/IEC 62304 processes that are related 
to the eleven selected CMMI
®
 process areas. The procedure for selecting the Med-Adept 
process areas was as follows:- 
Step 1. Select one of the eleven CMMI
®
 process areas (previously included in Adept – 
satisfies B in table 1); 
Step 2. Serially scan this process area against the following list of 16  AAMI/IEC 62304 
processes and select related ISO/IEC 15504-5 processes:- Risk Management, Configuration 
Management, Software Requirements Analysis, Software Development Planning, Software 
Architectural Design, Software Detailed Design, Software Integration, Software Unit 
Implementation and Verification, Integration Testing, Software System Testing, Quality 
Assurance, Software Release, Software Maintenance, Software Problem Resolution, 
Documentation, Software Safety Classification. 
Step 3. Repeat Steps 1 and 2 for each of the eleven CMMI
®
 process areas. 
As a result of performing these steps the CMMI
®
 to AAMI/IEC 62304 and ISO/IEC 15504-5 
processes (software related) area linkages were determined (see table 2) and the Med-Adept 
method provides coverage of 11 CMMI
®
 process areas, 12 ISO/IEC 15504-5 and 11 
AAMI/IEC 62304 processes.  
Table 2. CMMI
®
 to AAMI/IEC 62304 and ISO/IEC 15504-5 process linkages 
Med- Adept Processes 
Adept Processes  
Selected CMMI Process 
Area 
Selected ISO/IEC 
15504-5 Process 
AAMI/EC 62304 Process 
Risk Management Risk Management Risk Management  
Configuration Management Configuration Management Configuration Management 
Requirements 
Management 
 
Requirements 
Development 
Requirements Elicitation 
Software Requirements 
Analysis  
Software Requirements 
Analysis 
Project Planning 
 
Project Monitoring & 
Control 
Project Management Software Development 
Planning 
 
Technical Solution 
 
Software Design 
Software Construction 
Software Architectural Design  
Software Detailed Design 
Product Integration Software Integration  Software Integration 
Validation 
 
Verification  
Software Testing 
Verification 
Validation 
Software Unit Implementation 
and Verification 
Integration Testing 
Software System Testing 
Process and Product 
Quality Assurance 
Quality Management 
System 
Quality Assurance 
  
 
Software Release 
Software Maintenance  
 
Software Problem Resolution 
Documentation 
Software Safety Classification 
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It can also be observed that Med-Adept does not provide coverage of 5 AAMI/IEC 62304 
processes. However, the main purpose of Med-Adept is to provide a low overhead 
assessment that will educate organisations in relation to generic SPI and in particular medical 
device software development process. Therefore, it is not intended to provide comprehensive 
coverage of CMMI, AAMI/IEC 62304 and ISO/IEC 15504-5 processes, but rather a starting 
point through focusing upon the processes that will provide the most benefit to organisations. 
To encourage uptake of the Med-Adept assessment by Irish software organisations we wish 
to reduce the cost and time associated with the assessment.  On-site interviewing is restricted 
to one day as this proved attractive to companies in relation to performing the Adept 
assessment [22]. Consequently, an Med-Adept assessment method will be limited to 
providing coverage of four selected CMMI
®
 and (the related) AAMI/IEC 62304 and ISO/IEC 
15504-5 processes as the aim of Medi-Adept is to introduce organisations to medical device 
software processes in a low overhead manner. Companies wishing to be assessed in more 
than 4 of these processes will then be able to extend the assessment across additional days. 
4.2 The Stages of the Med-Adept Method 
The Med-Adept method is divided into eight stages and the assessment team consists of two 
assessors who conduct the assessment between them.  
Stage 1 (Develop Assessment Schedule and Receive Site Briefing) involves a preliminary 
meeting between the assessment team and the software company.  The assessment team 
will discuss the main drivers for the company embarking upon a Med-Adept assessment 
During stage 2 (Conduct Overview Briefing) the lead assessor provides an overview of the 
Med-Adept method for members of the organisation who will be involved in subsequent 
stages. Stage 3 (Analyse Key Documents) provides a brief insight into project documentation. 
The primary source of data for the Med-Adept method is through a series of process area 
interviews conducted during stage 4. The main part of the Med-Adept method is stage 4. In 
this stage key staff members from the assessed organisation are interviewed. In an attempt to 
reduce the overhead of the assessment we restrict the scope of the assessment to 4 process 
areas (there are a maximum of 4 interviews). Each interview is scheduled to last 
approximately 1.5 hours. Each interview involves two assessors, and at least one 
representative from the company is present for each process area interview. 
Table 3, illustrates (for example, the processes of risk management and configuration 
management) that the process interviews within an Med-Adept assessment includes 
additional questions to provide coverage of relevant AAMI/IEC 62304 and ISO/IEC 15504-5 
processes in addition to the CMMI process areas. When developing the interview questions 
we mainly looked at the base practices and did not perform a detailed investigation into 
similarities and differences between CMMI
®
, AAMI/IEC 62304 and ISO/IEC 15504-5.  Instead 
we checked the relevant interview questions from the Adept method to see if they covered 
their counterpart in AAMI/IEC 62304 and ISO/IEC 15504-5 processes. 
Table 3. Breakdown of Med-Adept Questions 
AHAA Interviews No. of Adept 
Questions 
No. of New 
Questions 
No. of Med-Adept 
Questions 
Risk Management 
39 23 62 
Configuration 
Management 39 2 41 
 
 
Within Adept 39 questions were used to provide coverage of the specific goals of the CMMI
®
 
and the base practices of ISO/IEC 15504-5 for risk management. Med-Adept is more 
comprehensive and has 62 scripted questions for risk management (see Table 3). Med-Adept 
not only contains CMMI and ISO/IEC 15504-5 based questions, but also 23 additional 
questions that are specifically related to the risk management process of AMMI/IEC 62304 
and other associated medical device standards and regulations. The configuration 
management process has 2 additional questions added to meet  the specific requirements of 
Med-Adept. 
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On completion of a Med-Adept assessment companies will receive feedback regarding the 
current state of their practices in relation to CMMI, AAMI/IEC 62304 and ISO/IEC 15504-5 
(unless a company specifies that they are only interested in one of the models). 
Stage 5 (Generate Assessment Results and Create the Findings Report) is a collaborative 
exercise between the assessors which results in the development of the findings report. The 
resultant findings report consists of a list of strengths, issues and suggested actions for each 
of the process areas evaluated. The findings report is developed through reviewing the 
interview notes for each of the 4 assessed process areas. Stage 6 (Deliver the findings 
report) involves presenting the findings report to the staff in the assessed organisation who 
participated in the interviews. Stage 7 (Develop a SPI Path with the Company) involves 
collaborating with staff from the assessed company to develop a roadmap that will provide 
guidance to the company in relation to practices that will offer the greatest benefits in terms of 
the organisation’s business goals. Companies wishing to become medical device software 
developers will be recommended to focus upon establishing working practices that will assist 
them to adhere to AAMI/IEC 62304 practices and to prepare them for future Medi SPICE 
assessments. Stage 8 (Re-assess the SPI Path and Produce a Final Report) involves 
revisiting the assessed company approximately 3 months after the completion of stage 7 and 
reviewing progress against the SPI path that was developed in stage 7. The outcome of this 
stage will be an updated SPI path and a final report detailing the progress that has been 
accomplished along with additional recommendations. This stage is important as it provides 
feedback and assistance to the assessed company after a period of time. This stage also 
assists in compiling research material in terms of SPI experiences.  
5 Observations from a Med-Adept assessment 
The Med-Adept assessment was performed in an Irish MD organisation MedSoft (a 
pseudonym). MedSoft were aware of CMMI and ISO/IEC 15504-5, but they had not 
previously utilized these process improvement models. Before undertaking the assessment 
they were not familiar with the AAMI/IEC 62304 MD standard. On completion of the 
assessment the software development manager stated it had been beneficial to MedSoft in a 
number of ways. These included the provision of high-level training in relation to CMMI and 
ISO/IEC 15504-5 in the areas of risk management and configuration management. In addition 
they gained an insight into the MD regulations that are required to achieve compliance for 
these specific practices. Another important outcome was the assessment provided an 
introduction to the MD software development standard AAMI/IEC 62304. MedSoft also 
recognised the benefits of having an external auditor and in this situation receiving guidance 
in relation to improving their configuration management and risk management processes. 
Furthermore MedSoft identified the benefits of utilizing the Med-Adept lightweight assessment 
which did not require preparation on their part and took very little time to perform. 
The results from the Med-Adept assessment highlighted that MedSoft’s configuration 
management processes were very strong with regard to control, but they could be improved 
in terms of management.  It also identified there was room for improvement in their risk 
management development practices. Therefore, if the recommendations in the Med-Adept 
findings report were implemented they would enable MedSoft to have both strong 
configuration and risk management practices.  
The software development manager and the engineer both agreed that the strengths and 
weaknesses highlighted in the report were an accurate reflection of the company’s risk 
management and configuration management practices. The management and staff of 
MedSoft also recognized that the recommendations were realistic and achievable and if 
implemented they would bring improvements and benefits to their organization. The software 
development manager stated that initially he intended championing these improvements in 
the location where the assessment took place. He then went on to state that he would 
oversee their implementation in other locations so that the overall organization could benefit 
from the assessment.  MedSoft representatives met internally to discuss developing a SPI 
path after the Med-Adept findings report was presented.  The objective of this meeting was to 
review and prioritise the report’s recommendations and to plan how they will be implemented 
in a new project (which is stage 7 of Med-Adept).  
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Having discussed the assessment process with the management of MedSoft they outlined the 
benefits it offered. They also requested that within 6 months their software processes would 
be re-assessed (which is stage 8 of Med-Adept). With the objective of receiving feedback 
regarding the progress of their SPI initiative. This will also provide the assessment team with 
an opportunity to validate and or refine their improvement recommendations. Regarding Med-
Adept the only area for improvement they identified was only 2 process areas had been 
assessed. It was agreed that on the release of the second edition of Med-Adept an additional 
assessment involving other software process areas will be undertaken. 
6 Conclusions and Future Plans 
The goal of the Med-Adept assessment is not certification but to provide a lightweight method 
for indicating to companies: the current state of their software processes; recommendations 
as to how they might improve; the status of their software processes both in terms of CMMI
®
 
and AAMI/IEC 62304 and ISO/IEC 15504-5; and their suitability to become medical device 
software developers. It is important to educate software development organisations in relation 
to how they may become medical device software developers and how they should improve 
their software development processes so that they may compete within this domain. This 
requires an appropriate approach that facilitates education and engages software 
development managers in a quality agenda. The application of the Med-Adept method will 
help raise the level of SPI knowledge within the assessed organisations. Also, the high-level 
findings report and the detailed SPI path will provide a road map for SPI within each assessed 
organisation.  Furthermore, as the Med-Adept method requires little internal staff time, this 
should prove attractive to SMEs from a resource viewpoint.  
From a research perspective the Med-Adept method: enables the Regulated Software 
Research Group (RSRG) at Dundalk Institute of Technology to gain an understanding as to 
whether existing software development practices within Irish companies are more CMMI, 
AAMI/IEC 62304 or ISO/IEC 15504-5 based. This will assists the RSRG in understanding 
areas that will present Irish software development companies with difficulties if they are to 
become medical device software development organisations – therefore this awareness will 
enable the RSRG to provide guidance within these areas; and will enable the RSRG to gain 
an understanding in relation to the strengths (profile) that Irish software companies possess 
particularly in relation to developing software for the medical device industry. 
This paper has described the development of the Med-Adept method that provides coverage 
of 11 CMMI
 
process areas, 12 ISO/IEC 15504-5 and 11 AAMI/IEC 62304 processes. It 
described a pilot release of the Med-Adept method, providing coverage of 2 processes. It also 
considered how a Med-Adept assessment was conducted in an Irish medical device software 
company. The company has since prioritised actions and are currently engaged in adopting a 
number of the recommendations as part of their software development practices.  In the 
future we plan to extend the number of processes that may be assessed. We will extend the 
Med-Adept assessment to provide coverage of the remaining nine applicable processes that 
are displayed in table 1.  
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